|
[1]Lok AS, McMahon BJ.Chronic hepatitis B[J].Hepatology, 2007, 45 (2) :507-539.
|
|
[2]Dienstag JL.Hepatitis B virus infection[J].N Engl J Med, 2008, 359 (14) :1486-1500.
|
|
[3]Liaw YF, Chu CM.Hepatitis B virus infection[J].Lancet, 2009, 373 (14) :582-592.
|
|
[4]Bertoletti A, Gehring AJ.The immune reponse during hepatitisB virus infection[J].J Gen Virol, 2006, 87 (7) :1439-1449.
|
|
[5]Wang FS, Zhang Z.Host immunity influences diseaseprogression and antiviral efficacy in humans infected withhepatitis B virus[J].Hepatol, 2009, 3 (5) :499-512.
|
|
[6]Boonstra A, Woltman AM, Janssen HL.Immunology of hepatitisB and hepatitis C virus infection[J].Best Pract Res ClinGastroenterol, 2008, 22 (6) :1049-1061.
|
|
[7]Szabo G, Mandrekar P, Dolganiuc A.Innate immune response andhepatic inflammation[J].Semin Liver Dis, 2007, 27 (4) :339-350.
|
|
[8]Tahar MS, Touqui L, Chignard M.Innate immunity andinflammation-two facets of the same anti-infectious reaction[J].Clin Exp Immuno, 2009, 156 (3) :194-198.
|
|
[9]Mogensen TH.Pathogen recognition and inflammatorysignaling in innate immune defense[J].Clin Microbiol Rev, 2009, 22 (2) :240-273.
|
|
[10]Xagorari A, Chlichlia K.Toll-like receptors and viruses:inductionof innate antiviral immune responses[J].Open Microbiol J, 2008, 2 (8) :49-59.
|
|
[11]Lund J, Sato A, Akira S, et al.Toll-like receptor 9-mediatedrecognition of herpes simplex virus-2 by plasmacytoid dendriticcells[J].J Exp Med, 2003, 198 (3) :513-520.
|
|
[12]Takaoka A, Yanai H.Interferon signaling network in innatedefence[J].Cell Microbiol, 2006, 8 (6) :907-922.
|
|
[13]Kawai T, Akira S.Antiviral signaling through pattern recognitionreceptors[J].J Biochem, 2007, 141 (2) :137-145.
|
|
[14]Sadler AJ, Williams BR.Interferon inducible antiviral effectors[J].Nat Rev Immunol, 2008, 8 (7) :559-568.
|
|
[15]Isogawa M, Robek MD, Furuichi Y, et al.Toll-like receptorsignaling inhibits hepatitis B virus replication in vivo[J].J Virol, 2005, 79 (11) :7269-7272.
|
|
[16]刘华, 陈志翱, 成玉明, 等.乙型肝炎病毒表面抗原抑制TLR2和TLR4的激活[J].微生物与感染, 2008, 2 (3) :84-89.
|
|
[17]Riordan SM, Skinner N, Kurtovic J, et al.Reduced expression oftoll-like receptor 2 on peripheral monocytes in patients with chronichepatitis B[J].Clin Vaccine Immunol, 2006, 13 (8) :972-974.
|
|
[18]Chen Z, Cheng Y, Xu YF, et al.Expression profiles andfunction of Toll-like receptors 2 and 4 in peripheral bloodmononuclear cells of chronic hepatitis B patients[J].CliniImmunol, 2008, 128 (3) :400-408.
|
|
[19]Visvanathan K, Skinner NA, Thompson AJ, et al.Regulation ofToll-like receptor-2 expression in chronic hepatitis B by theprecore protein[J].Hepatology, 2007, 45 (1) :102-110.
|
|
[20]Zhang Y, Lian JQ, Huang CX, et al.overexpression of Toll-like receptor 2/4 on moncytes modulates the activities ofCD4+CD25+regulatory T cells in chronic hepatitis B virusinfection[J].Virology, 2010, 397 (1) :34-42.
|
|
[21]Ratnam D, Visvanathan K.New concepts in theimmunopathogenesis of chronic hepatitis B:the importanceof the innate immune reponse[J].Hepatol Int, 2008, 2 (Suppl1) :s12-s18.
|
|
[22]Xu N, Yao HP, Sun Z, et al.Toll-like receptor 7 and 9expression in peripheral blood mononuclear cells frompatients with chronic hepatitis B and related hepatocellularcarcinoma[J].Acta Pharmacol Sin, 2008, 29 (2) :239-244.
|
|
[23]Xie Q, Shen HC, Jia NN, et al.Patients with chronic hepatitisB infection display deficiency of plasmacytoid dendritic cellswith reduced express of TLR9[J].Microbes infect, 2009, 11 (2) :515-521.
|
|
[24]Chen Y, Wei H, Gao B, et al.Activation and function ofhepatic NK cells in hepatitis B infection:an underinvestigatedinnate immuner response[J].J Viral Hepat, 2005, 12 (1) :38-45.
|
|
[25]Kondo Y, Ueno Y, Shimosegawa, et al.Immunopathpgenesisof hepatitis B persistent infection:implication forimmunotherapeutic strategies[J].Clin J gastroenterology, 2009, 2 (2) :71-79.
|
|
[26]Paturel CA, Trinchieri G.Production of type Iinterferons:plasmacytoid dendritic cells and beyond[J].JExp Med, 2005, 202 (4) :461-465.
|
|
[27]Wang K, Fan X, Fan Y, et al.Study on the fuction ofcirculating plasmacytoid dendritic cells in the immunoactivephase of patients with chronic genotype B and C HBVinfection[J].J Viral Hepat, 2007, 14 (4) :276-282.
|
|
[28]Gabriele L, Ozato K.The role of the interferon regulatoryfactor (IRF) family in dendritic cell development and fuction[J].Cytokine Growth Factor Rev, 2007, 18 (5) :503-510.
|
|
[29]Honda K, Yanai H, Mizutani T, et al.Role of a transductional-transcriptional processor complex involving MyD88 andIRF-7 in Toll-like receptor signaling[J].Proc Natl Acad SciUSA, 2004, 101 (43) :15416-15421.
|
|
[30]Xu YF, Hu YW, Shi BS, et al.HBsAg inhibits TLR9-mediatedactivation and IFN-αproduction in plamacytoid dendriticcells[J].Mol Immunol, 2009, 46 (13) :2640-2646.
|
|
[31]Moynagh PN.TLR signalling and activation of IRFs:revisitingold friends from the NF-kappaB pathway[J].TrendsImmunol, 2005, 26 (9) :469-476.
|
DownLoad: